Literature DB >> 19043508

Exercise and febrile illnesses.

.   

Abstract

Year:  2007        PMID： 19043508      PMCID： PMC2532567          DOI： 10.1093/pch/12.10.885

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  5 in total

Review 1.  Is infection risk linked to exercise workload?

Authors:  D C Nieman
Journal:  Med Sci Sports Exerc       Date:  2000-07       Impact factor: 5.411

2.  Infectious mononucleosis: ensuring a safe return to sport.

Authors:  John M Macknight
Journal:  Phys Sportsmed       Date:  2002-01       Impact factor: 2.241

Review 3.  Upper respiratory tract infections: who plays, who sits?

Authors:  John P Metz
Journal:  Curr Sports Med Rep       Date:  2003-04       Impact factor: 1.733

Review 4.  Infectious mononucleosis and the spleen.

Authors:  James J Kinderknecht
Journal:  Curr Sports Med Rep       Date:  2002-04       Impact factor: 1.733

5.  Hepatosplenomegaly in infectious mononucleosis, assessed by ultrasonic scanning.

Authors:  H Dommerby; S E Stangerup; M Stangerup; S Hancke
Journal:  J Laryngol Otol       Date:  1986-05       Impact factor: 1.469
  5 in total
  3 in total

Review 1.  Urgent wake up call for the National Basketball Association.

Authors:  Meeta Singh; Stephen Bird; Jonathan Charest; Thomas Huyghe; Julio Calleja-Gonzalez
Journal:  J Clin Sleep Med       Date:  2021-02-01       Impact factor: 4.062

2.  Febrile illness in the athlete.

Authors:  Natalie A Dick; Jason J Diehl
Journal:  Sports Health       Date:  2014-05       Impact factor: 3.843

3.  How much is too much? (Part 2) International Olympic Committee consensus statement on load in sport and risk of illness.

Authors:  Martin Schwellnus; Torbjørn Soligard; Juan-Manuel Alonso; Roald Bahr; Ben Clarsen; H Paul Dijkstra; Tim J Gabbett; Michael Gleeson; Martin Hägglund; Mark R Hutchinson; Christa Janse Van Rensburg; Romain Meeusen; John W Orchard; Babette M Pluim; Martin Raftery; Richard Budgett; Lars Engebretsen
Journal:  Br J Sports Med       Date:  2016-09       Impact factor: 13.800
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.